Pedro Fontes

Pedro Fontes is a Researcher with expertise in oncology, biostatistics, and pharmaceutical sciences. His work focuses on understanding the impact of body-mass index (BMI) on survival rates of advanced melanoma patients, utilizing statistical models such as Cox regression. His research contributes to the UN Sustainable Development Goals related to health and well-being.

Education:

• MSc in Pharmaceutical Sciences, University of Porto (Awarded: 15 Nov 2019)

Research Interests:

• Melanoma treatment outcomes
• Survival analysis in oncology
• Biostatistical methods (e.g., Cox models)
• Cancer patient demographics and biomarkers

Projects:

• Principal Investigator/Researcher in the 'Cancer Medicines Outcomes Programme Interim 23-24' (2023–2024), focusing on malignant neoplasm and pharmaceutical outcomes research.

Key Activities:

• Presenter at the British Oncology Pharmacy Association (BOPA) 2022 Annual Symposium.
• Participant in the 44th Research Students’ Conference in Probability and Statistics (2021).